Agree Kevi. I hold quite a few ORD as from research it seemed like it had great potential. The SPP has held it back for sometime so it's very ready for a run now. The ann. will get just the right publicity it needs. Go ORD.GL all holders.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
